TECTONIC THERAPEUTIC, INC. Other Current Assets
TECTONIC THERAPEUTIC, INC. (TECX) had Other Current Assets of $626.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2024-05-09
- 2024-03-31: Other Assets, Current $626.00K.
- 2023-12-31: Other Assets, Current $570.00K.
- 2023-09-30: Other Assets, Current $805.00K.
- 2023-06-30: Other Assets, Current $792.00K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2024-03-31 | $626.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $570.00K 10-Q · filed 2024-05-09 | |
| 2023-09-30 | $805.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $792.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $845.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.01M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $765.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $555.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $805.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.70M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $522.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $516.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $387.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $271.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $1.16M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $997.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $966.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $344.00K 10-K · filed 2021-03-18 | $620.00K 10-K · filed 2020-03-16 |
| 2019-09-30 | $247.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $329.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $475.00K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $795.00K 10-K · filed 2020-03-16 | |
| 2018-09-30 | $469.00K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $294.00K 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $60.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |